From: GSK-3β inhibits autophagy and enhances radiosensitivity in non-small cell lung cancer
Clinicopathological factors | GSK-3β expression | ||
---|---|---|---|
– | + | P value | |
Sex | |||
Male | 50 | 17 | |
Female | 18 | 4 | 0.491 |
Age (years) | |||
< 59 | 36 | 6 | |
≥ 59 | 32 | 15 | 0.051 |
Histologic type | |||
SCC | 31 | 14 | |
AC | 34 | 7 | |
Others | 3 | 0 | 0.192 |
Differentiation | |||
Well | 8 | 8 | |
Moderate | 33 | 8 | |
Poor | 27 | 5 | 0.021 |
pTNM stage* | |||
I-II | 45 | 15 | |
III | 23 | 6 | 0.894 |